| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/26/2005 | US20050112729 Recombinant DNA having hydantoinase gene and carbamylase gene and process for producing amino acid |
| 05/26/2005 | US20050112728 Polynucleotide coding enzyme catalyst for biosynthesis; gene expression; forming antibiotic |
| 05/26/2005 | US20050112727 For producing a glycosaminoglycan |
| 05/26/2005 | US20050112726 Biosynthetic gene cluster for leptomycins |
| 05/26/2005 | US20050112725 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/26/2005 | US20050112723 Mammalian cell lines specifically deficient in O-linked glycosylation |
| 05/26/2005 | US20050112722 Protein gene expression; high density culture |
| 05/26/2005 | US20050112719 Product and process for transformation of thraustochytriales microorganisms |
| 05/26/2005 | US20050112714 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof |
| 05/26/2005 | US20050112709 Histone h3methyltransferase polypeptide |
| 05/26/2005 | US20050112705 Detecting cancer perticularly of prostate gland |
| 05/26/2005 | US20050112696 Determination moderator of beta-secretase on proteins |
| 05/26/2005 | US20050112692 Screening peptide library; incubation complexing |
| 05/26/2005 | US20050112683 Protein sequence analysis apparatus, methods, computer-readable media, computer programs, signals and data structures |
| 05/26/2005 | US20050112682 Green fluorescent fusion protein as diagnosis tool; quantitative analysis; colorimetic analysis |
| 05/26/2005 | US20050112681 Isolated human transporter proteins, nucleic acid molecules encoding human, transporter proteins, and uses thereof |
| 05/26/2005 | US20050112675 Polypeptides gene expressed in fat tissue ; measurement concentration; using antibodies |
| 05/26/2005 | US20050112670 Chromosome state analysis |
| 05/26/2005 | US20050112669 Glutamate receptor transport protein peptide for use in treatment and prevention of nervous system and cell proliferative disorders |
| 05/26/2005 | US20050112668 Determination sensitivity for development fat metabolism diosrders by comparison of gene expression levels |
| 05/26/2005 | US20050112665 Novel VEGF-like factor |
| 05/26/2005 | US20050112663 Nucleic acids encodin gpolypeptide; therapy for genetic disorders, antiepileptic agents, hypotensive agents, cystic fibrosis, muscular disorders |
| 05/26/2005 | US20050112662 Human potassium channel genes |
| 05/26/2005 | US20050112661 Methods for delivering nucleic acid molecules into cells and assessment thereof |
| 05/26/2005 | US20050112660 Nucleotide sequence coding membrane protein; diagnosis, therapy of nervous system, psychological, brain disorders |
| 05/26/2005 | US20050112658 Using adsorptive porous membrane |
| 05/26/2005 | US20050112656 Method for isolating and purifying nucleic acid, cartridge for isolating and purifying nucleic acid, and kit isolating and purifying nucleic acid |
| 05/26/2005 | US20050112647 Amplifying target sequence in presence of duplex binding agent, polymerase and labeled primer/probe, recovering product and monitoring fluorescence; kits; solid phase synthesis; gene therapy |
| 05/26/2005 | US20050112645 Detecting unit for detecting hybridization and other interactions and DNA chip and other bioassay substrates having the detecting unit |
| 05/26/2005 | US20050112643 Polypeptide related to the kinase family; cell mtosis; detection binding pattern |
| 05/26/2005 | US20050112641 Protein mixture which confers antibiotic resistance |
| 05/26/2005 | US20050112640 Nucleotide sequence for coding polypeptides for diagnosis,and cancer therapy, nervous system disorders, muscular disorders |
| 05/26/2005 | US20050112639 Propagating/replicating preferential nucleotide/gene sequences using circular plasmid; genetic engineering and heterologous gene expression |
| 05/26/2005 | US20050112638 Screening agent that moderates post-transcriptional control of angiotensin receptors; hypotensive agents |
| 05/26/2005 | US20050112629 Detection reagent for thermostable direct hemolysin gene of Vibrio parahaemolyticus |
| 05/26/2005 | US20050112628 Amplification using oligonucleotide primers |
| 05/26/2005 | US20050112626 Making and using microclonal uncloned cDNA libraries |
| 05/26/2005 | US20050112619 Length determination of nucleic acid repeat sequences by discontinuous primer extension |
| 05/26/2005 | US20050112608 Probe composition and method |
| 05/26/2005 | US20050112603 Method for purification, modification and immobilization of recombinant protein |
| 05/26/2005 | US20050112596 APRIL-A novel protein with growth effect |
| 05/26/2005 | US20050112594 Detecting target nucleic acid sequences; obtaining sample; incubation; monitoring migration of nucleotide sequence |
| 05/26/2005 | US20050112593 Novel inducible genes from alfalfa and method of use thereof |
| 05/26/2005 | US20050112590 Spectrometric analysis ; splitting compound; measurement signals; calibration |
| 05/26/2005 | US20050112578 Hybridization of oligonucleotides; three-dimensional; receptivity terminals |
| 05/26/2005 | US20050112576 Vectors containing promoters; contacting with lymphocytes; inducting antigen presenting cells transduced with vector; encoding marking gene; gene transfer vectors |
| 05/26/2005 | US20050112575 Nucleic acid sequence encoding polypeptides; triggering calcium oscillation in ooctyes ; determination fertility |
| 05/26/2005 | US20050112574 Isolated nucleic acid; angiogenesis inhibitor |
| 05/26/2005 | US20050112572 Detecting oxidation stresses in sampling using markers; measurement; calibration |
| 05/26/2005 | US20050112571 Dna molecules conferring tolerance to herbicidal compounds |
| 05/26/2005 | US20050112570 Indicator for development of diabetes |
| 05/26/2005 | US20050112568 Dgks as modifiers of the p53 pathwha and methods of use |
| 05/26/2005 | US20050112566 Free of solvents, chemicals, grinders, freezing, or detergents to remove the macromolecules from DNA, RNA, saccharide, protein, lipid biological materials; outer covering interruption; steady-state radio frequency |
| 05/26/2005 | US20050112565 Proteases |
| 05/26/2005 | US20050112563 Sub-sequences of 2'-deoxy-erythro-pentofuranosyl nucleotides that activate RNase H enzyme; diagnostics; antisense therapeutics |
| 05/26/2005 | US20050112556 Drug screening; endogenous human retrovirus; protein or peptide expressed by said retrovirus |
| 05/26/2005 | US20050112553 Screening a compound for effectiveness in treating a viral infection, a cellular gene functionally encoding a gene product whose overexpression inhibits reproduction of the virus but does not prevent survival of the cell; detecting the level of the gene product produced |
| 05/26/2005 | US20050112551 screening for compounds that modulate cell receptor activity; target cells can be constructed that constitutively express a reporter gene responsive to cell viability; improved Renilla reniformis luciferase (rluc) genes |
| 05/26/2005 | US20050112550 Phage display vector, phages encoded thereby, and methods of use thereof |
| 05/26/2005 | US20050112548 Unit for detecting interaction between substances utilizing capillarity, and method and bioassay substrate using the detecting unit |
| 05/26/2005 | US20050112237 food additive with a PS4 variant polypeptide derivable from a parent polypeptide having non-maltogenic exoamylase activity; baked goods; glucan 1,4-alpha-maltotetrahydrolase activity |
| 05/26/2005 | US20050112203 Chain extended polyetherurethane derived from a carboxy-functional diisocyanate modified with an amino compound to form 3-aminoalkylamide linkages; units of ethylene glycol, lysine diisocyanate, N,N-diethylethylenediamine, and N-methyldiethanolamine for example; for gene delivery |
| 05/26/2005 | US20050112185 Positively charged lipid and liposome with the lipid |
| 05/26/2005 | US20050112150 Promoting exfoliation; mixture of polypeptide and protease; skin disorders; antitumor agents |
| 05/26/2005 | US20050112145 Dna vaccines coding antigen |
| 05/26/2005 | US20050112136 Human immunodeficiency virus vaccine |
| 05/26/2005 | US20050112133 Chimera molecule containing protein and merozonite surface protein; induce immunologyresponse against antigens |
| 05/26/2005 | US20050112127 Treating with active material having heavy chain variable region of amino acid sequence 7 and light chain variable region of sequence 8; psoriasis, multiple sclerosis, Crohn's disease |
| 05/26/2005 | US20050112126 Anti-VEGF antibodies |
| 05/26/2005 | US20050112121 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 05/26/2005 | US20050112118 Compositions and methods for treating inflammatory disorders |
| 05/26/2005 | US20050112117 Molecules and methods for inhibiting shedding of KIM-1 |
| 05/26/2005 | US20050112110 Isolated polynucleotide sequences; controlling neovasculization; cell growth regulators |
| 05/26/2005 | US20050112103 Genetic engineered vectors encoding human low density lipoproteins ; control sequencing, gene expressionin heptacytes; anticholesterol agents; antilipemic agents |
| 05/26/2005 | US20050112102 Viral proteins which stimulating immunology response |
| 05/26/2005 | US20050112101 Methods of treating restenosis |
| 05/26/2005 | US20050112100 Sp1 and Sp3 targeted cancer therapies and therapeutics |
| 05/26/2005 | US20050112096 Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV) |
| 05/26/2005 | US20050112095 Internal ribosome entry sites for recombinant protein expression |
| 05/26/2005 | US20050112036 Bonding substrate and elastomer forming fluid flow channels; forming concave, convex joints |
| 05/26/2005 | US20050111299 Device for mixing and/or injecting cements |
| 05/26/2005 | CA2812856A1 Interleukin-10 antibodies |
| 05/26/2005 | CA2805859A1 Il-18 binding proteins |
| 05/26/2005 | CA2793127A1 Oligonucleotides and methods for detection of west nile virus |
| 05/26/2005 | CA2552686A1 Isolation of nucleic acid from mouth epithelial cells |
| 05/26/2005 | CA2548080A1 Porcine isogloboside 3 synthase protein, cdna, genomic organization, and regulatory region |
| 05/26/2005 | CA2546243A1 The mycolactone locus : an assembly line for producing novel polyketides, with therapeutic and prophylatic uses |
| 05/26/2005 | CA2545938A1 High-titer retroviral packaging cells |
| 05/26/2005 | CA2545807A1 Oligonucleotides and methods for detection of west nile virus |
| 05/26/2005 | CA2545756A1 Antibodies against secretoryleukocyte protease inhibitor |
| 05/26/2005 | CA2545755A1 Plasmid system for multigene expression |
| 05/26/2005 | CA2545603A1 Neonatal fc receptor (fcrn)-binding polypeptide variants, dimeric fc binding proteins and methods related thereto |
| 05/26/2005 | CA2545590A1 Template fixed beta-hairpin loop mimetics and their use in phage display |
| 05/26/2005 | CA2545260A1 Compositions and methods for modulating c-rel-dependent cytokine production |
| 05/26/2005 | CA2545183A1 Custom vectors for treating and preventing pancreatic cancer |
| 05/26/2005 | CA2545182A1 Improved methods and compositions for rna interference |
| 05/26/2005 | CA2545164A1 Recombinant vectors expressing mucin and carcinoembryoinic antigen |
| 05/26/2005 | CA2545053A1 Expression in filamentous fungi of protease inhibitors and variants thereof |
| 05/26/2005 | CA2544976A1 Method of preparing nucleic acids for detection |
| 05/26/2005 | CA2544820A1 Bacterial expression of protease inhibitors and variants thereof |